Orange Book product · Generic (ANDA)
LIDOCAINE AND PRILOCAINE
LIDOCAINE; PRILOCAINE
At a glance
Aug 18, 2003
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 18, 2003
23 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
LIDOCAINE; PRILOCAINE
Strength
2.5%;2.5%
Dosage form
CREAM
Route
TOPICAL
TE code
AB
Application
ANDA 076453
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of LIDOCAINE; PRILOCAINE
- 2003ORAQIXBrand (NDA)
NDA 021451 · DENTSPLY PHARM
- 1998EMLABrand (NDA)
NDA 020962 · ASTRAZENECA
- 1992EMLABrand (NDA)
NDA 019941 · TEVA BRANDED PHARM
- 2024LIDOCAINE AND PRILOCAINEGeneric (ANDA)
ANDA 219120 · ZYDUS LIFESCIENCES
- 2022LIDOCAINE AND PRILOCAINEGeneric (ANDA)
ANDA 213923 · ALEMBIC
- 2021LIDOCAINE AND PRILOCAINEGeneric (ANDA)
ANDA 212482 · PADAGIS US
- 2020LIDOCAINE AND PRILOCAINEGeneric (ANDA)
ANDA 213253 · CHARTWELL RX
- 2018LIDOCAINE AND PRILOCAINEGeneric (ANDA)
ANDA 205887 · PAI HOLDINGS PHARM
- 2003LIDOCAINE AND PRILOCAINEGeneric (ANDA)
ANDA 076290 · HIKMA
- 2003LIDOCAINE AND PRILOCAINEGeneric (ANDA)
ANDA 076320 · ENCUBE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
